Axogen (NASDAQ:AXGN) specializes in innovative solutions for peripheral nerve injuries. The company is deeply involved in the development and commercialization of surgical nerve repair solutions that aim to restore functionality and improve the quality of life for patients suffering from physical damage or trauma to peripheral nerves. This ambitious objective is pursued through a diverse portfolio of products including Avance® Nerve Graft, AxoGuard® Nerve Connector, and AxoGuard® Nerve Protector, among others, each designed to address different aspects of nerve repair and protection. Axogen's projects range from research and development in nerve regeneration to clinical studies aimed at advancing the field of peripheral nerve repair. The company's overarching goal is to continue pioneering in the nerve repair space, striving to bring innovative and effective treatments to patients worldwide.